Lv1
33 积分 2021-12-15 加入
Expert consensus on the treatment of dermatoses with targeted drugs (2025 version)
12小时前
待确认
Atopic Dermatitis and Psoriasis: Similarities and Differences in Metabolism and Microbiome
3天前
已完结
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials
1个月前
已完结
Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial
1个月前
已完结
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
1个月前
已完结
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update
1个月前
已完结
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
1个月前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
2个月前
已完结
A Review on the Mechanisms and Clinical Advances of JAK Inhibitors in the Treatment of Rosacea
2个月前
已完结
Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study
2个月前
已完结
皖公网安备34019202002308
